Showing results (191-200 of 463) with videos related to

Sort By:
Pageof 47
Psychiatric Genetics|October 22, 2019
Modification of the association between paroxetine serum concentration and SERT-occupancy by ABCB1 (P-glycoprotein) polymorphisms in major depressive disorderMirjam Simoons, Hans Mulder, Jerôme T Y Appeldoorn, et al.
Drug Metabolism and Personalized Therapy|June 4, 2015
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in EuropeFrancesca Malentacchi, Irene Mancini, Ivan Brandslund, et al.
Clinical Chemistry and Laboratory Medicine|May 22, 2015
Is laboratory medicine ready for the era of personalized medicine? A survey addressed to laboratory directors of hospitals/academic schools of medicine in EuropeFrancesca Malentacchi, Irene Mancini, Ivan Brandslund, et al.
Journal of Inherited Metabolic Disease|June 9, 2020
Cognitive functioning and depressive symptoms in Fabry disease: A follow-up studySimon Körver, Gert J Geurtsen, Carla E M Hollak, et al.
Annals of Neurology|December 11, 2008
Randomized, controlled trial of miglustat in Gaucher's disease type 3Raphael Schiffmann, Edmond J Fitzgibbon, Chris Harris, et al.
Brain : a Journal of Neurology|August 10, 2010
Peripheral neuropathy in adult type 1 Gaucher disease: a 2-year prospective observational studyMarieke Biegstraaten, Eugen Mengel, Laszlo Maródi, et al.
Pharmacogenomics|August 27, 2014
Rescue morphine in mechanically ventilated newborns associated with combined OPRM1 and COMT genotypeMaja Matic, Sinno H P Simons, Richard A van Lingen, et al.
Therapeutic Drug Monitoring|September 21, 2013
Impact of CYP3A4*22 allele on tacrolimus pharmacokinetics in early period after renal transplantation: toward updated genotype-based dosage guidelinesLaure Elens, Arnaud Capron, Ron H N van Schaik, et al.
Breast Cancer Research and Treatment|February 4, 2009
The CYP2D6*4 polymorphism affects breast cancer survival in tamoxifen usersMonique J Bijl, Ron H N van Schaik, Laureen A Lammers, et al.
Therapeutic Drug Monitoring|July 12, 2011
CYP3A5, ABCB1, and SLCO1B1 polymorphisms and pharmacokinetics and virologic outcome of lopinavir/ritonavir in HIV-infected childrenNatella Y Rakhmanina, Michael N Neely, Ron H N Van Schaik, et al.
Pageof 47